መነሻ › የጡንቻ ካንሰር › ኮነቲከት › New Haven
በNew Haven፣ CT ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየጡንቻ ካንሰር የሚደረጉ 38 ጥናቶች በNew Haven እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Yale-New Haven Hospital-Yale Cancer Center, New Haven
A Study of PHST001 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Yale Cancer Center, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Yale Cancer Center, New Haven
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Yale University School of Medicine - Yale Cancer Center, New Haven
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Yale University School of Medicine, New Haven
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Yale Cancer Center, New Haven
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Yale University - Yale University School of Medicine, New Haven
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Yale Cancer Center, New Haven
Study of AVZO-021 in Patients With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Yale Cancer Center ( Site 0060), New Haven
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, New Haven
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale University/Yale Cancer Center/Yale School of Medicine, New Haven
- Smilow Cancer Hospital Care Center - North Haven, North Haven · 7 ማይል ርቀት
- እና 2 ተጨማሪ
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
ተሳታዮችን በመፈለግ ላይ
- Yale Cancer Center, New Haven
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Clinical Trial Site, New Haven
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Yale University School Of Medicine, New Haven
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Yale Cancer Center Clinical Trials Office, New Haven
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Yale New Haven Hospital- Yale Cancer Center, New Haven
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Yale Cancer Center, New Haven
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Smilow Cancer Hospital at Yale New Haven, New Haven
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 ማይል ርቀት
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 ማይል ርቀት
- እና 1 ተጨማሪ
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Yale Cancer Center, New Haven
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Yale University Cancer Center, New Haven
ATEMPT 2.0: Adjuvant T-DM1 vs TH
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Yale Cancer Center at Yale University School of Medicine, New Haven
- Smilow Cancer Hospital Care center at North Haven, North Haven · 7 ማይል ርቀት
- Smilow Cancer Hospital Care center at Derby, Derby · 8 ማይል ርቀት
- እና 1 ተጨማሪ
Optimizing Surgical Decisions in Young Adults With Breast Cancer
ተሳታዮችን በመፈለግ ላይ
- Yale Cancer Center, New Haven
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Yale Cancer Center - Smilow Cancer Hospital, New Haven
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Yale University, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Yale University, Yale Cancer Center, New Haven
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Yale Cancer Center Smilow Cancer Hospital, New Haven
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Yale Cancer Center, New Haven
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Yale Cancer Center, New Haven
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Smilow Cancer Hospital - North Haven, North Haven · 7 ማይል ርቀት
- Smilow Cancer Hospital - Derby, Derby · 8 ማይል ርቀት
- እና 1 ተጨማሪ
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Yale-New Haven Hospital Saint Raphael Campus, New Haven
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · 5 ማይል ርቀት
- እና 4 ተጨማሪ
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Yale University, Yale Cancer Center, New Haven
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
ተሳታዮችን በመፈለግ ላይ
- Yale University, New Haven
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Yale University, New Haven
The Cancer of the Pancreas Screening-5 CAPS5)Study
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Yale University, New Haven
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Yale University, New Haven
በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች
- New York City, NY136 ጥናቶች
- Houston, TX126 ጥናቶች
- Boston, MA112 ጥናቶች
- Nashville, TN81 ጥናቶች
- Los Angeles, CA73 ጥናቶች
- Edison, NJ68 ጥናቶች
- St. Louis, MO64 ጥናቶች
- Queens, NY64 ጥናቶች
- Durham, NC64 ጥናቶች
- Chicago, IL59 ጥናቶች
- Philadelphia, PA56 ጥናቶች
- Dallas, TX55 ጥናቶች
በNew Haven ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር41 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)33 ጥናቶች
- Metastatic Cancer23 ጥናቶች
- የሳንባ ካንሰር22 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ22 ጥናቶች
- የእንቁላል ካንሰር21 ጥናቶች
- የኮሎሬክታል ካንሰር20 ጥናቶች
- የፕሮስቴት ካንሰር20 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ17 ጥናቶች
- የአልኮል ጥቅም ችግር (AUD)17 ጥናቶች
- የኦፒኦይድ መጠን መብለጥ17 ጥናቶች
- የፓንክሪያስ ካንሰር16 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።